Panuveitis after covishield vaccination in an undiagnosed immunocompromised patient: A rare case report from Nepal

Authors

DOI:

https://doi.org/10.3126/jkmc.v11i2.53073

Keywords:

Coronavirus disease 2019, Immunocompromised , Panuveitis , Vaccination

Abstract

With the emergence of vaccines for the novel coronavirus, a new ray of hope came into human society. Yet the adverse effects of vaccination on some candidates without allergic tests might cause a detrimental change in the future. An interesting case of panuveitis in a 34-year-old male after the ChAdOx1 nCoV19 (covishield) vaccination is reported here. The respective management of the patient was done after comprehensive ocular and systemic evaluation. It is understood that vaccination is vital in controlling this pandemic, but the immunologic response due to this novel vaccine is also a concern.

Downloads

Download data is not yet available.
Abstract
49
PDF
71

Author Biographies

Bipin Bista, BP Koirala Lions Centre for Ophthalmic Studies, Institute of Medicine, Maharajgunj, Kathmandu, Nepal

Vitreoretina Surgery Fellow

Reena Yadav, Sagarmatha Choudhary Eye Hospital, Lahan, Siraha, Nepal

Consultant Ophthalmologist

Sandip Das Sanyam, Sagarmatha Choudhary Eye Hospital, Lahan, Siraha, Nepal

Clinical Research Coordinator

Sushma Chaudhary, Sagarmatha Choudhary Eye Hospital, Lahan, Siraha, Nepal

Optometrist

Abinash Chaudhary, Sagarmatha Choudhary Eye Hospital, Lahan, Siraha, Nepal

Ophthalmic Assistant

Sharad Gupta, Sagarmatha Choudhary Eye Hospital, Lahan, Siraha, Nepal

Consultant Ophthalmologist

References

https://covid19.mohp.gov.np/

Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American journal of ophthalmology. 2005 Sep 1;140(3):509-16.[FULLTEXT] [DOI]

Couture S, Agrawal R, Woods K, Lockwood D, Pavesio CE, Addison PK. A case of panuveitis with hypopyon due to presumed ocular leishmaniasis in a HIV patient. Journal of ophthalmic inflammation and infection. 2014 Dec;4(1):1-5. [FULLTEXT] [DOI]

Pinon-Mosquera R, Jimenez-Benito J, Olea-Cascon J. Syphilitic bilateral panuveitis: a case report. Archivos de la Sociedad Espanola de Oftalmologia. 2009 Feb 1;84(2):101-4. [FULLTEXT] [DOI]

Tien PT, Lin CJ, Tsai YY, Chen HS, Hwang DK, Muo CH, Lin JM, Chen WL. Relationship between uveitis, different types of viral hepatitis, and liver cirrhosis: a 12-year nationwide population-based cohort study. Retina (Philadelphia, Pa.). 2016 Dec;36(12):2391. [FULLTEXT] [DOI]

Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocular Immunology and Inflammation. 2021 May 19;29(4):741-2. [FULLTEXT] [DOI]

Reddy Y, Pandey A, Ojha A, Ramchandani S. Harada-like syndrome post-Covishield vaccination: A rare adverse effect. Indian journal of ophthalmology. 2022 Jan 1;70(1):321-3. [FULLTEXT] [DOI]

Chau CY, Chow LL, Sridhar S, Shih KC. Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders. Ophthalmology and Therapy. 2021 Jun;10(2):201-9. [FULLTEXT] [DOI]

Agarwal M, Majumder PD, Babu K, Konana VK, Goyal M, Touhami S, Stanescu-Segall D, Bodaghi B. Drug-induced uveitis: A review. Indian Journal of Ophthalmology. 2020 Sep;68(9):1799. [FULLTEXT] [DOI]

Vounotrypdis P. COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment. Mediterranean Journal of Rheumatology. 2020 Sep;31(Suppl 2):275. [FULLTEXT] [DOI]

Martins-Chaves RR, Gomes CC, Gomez RS. Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care. Brazilian oral research. 2020 May 15;34. [FULLTEXT] [DOI]

Ritchie AI, Singanayagam A. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?. The Lancet. 2020 Apr 4;395(10230):1111. [FULLTEXT] [DOI]

Downloads

Published

2022-07-01

How to Cite

Bista, B., Yadav, R., Sanyam, S. D., Chaudhary, S., Chaudhary, A., & Gupta, S. (2022). Panuveitis after covishield vaccination in an undiagnosed immunocompromised patient: A rare case report from Nepal. Journal of Kathmandu Medical College, 11(2), 128–130. https://doi.org/10.3126/jkmc.v11i2.53073

Issue

Volume 11, Number 2, Issue 40, April - June 2022

Section

Case Reports

License

Copyright (c) 2023 Journal of Kathmandu Medical College

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © Journal of Kathmandu Medical College
The ideas and opinions expressed by authors or articles summarized, quoted, or published in full text in this journal represent only the opinions of the authors and do not necessarily reflect the official policy of Journal of Kathmandu Medical College or the institute with which the author(s) is/are affiliated, unless so specified.

Authors convey all copyright ownership, including any and all rights incidental thereto, exclusively to JKMC, in the event that such work is published by JKMC. JKMC shall own the work, including 1) copyright; 2) the right to grant permission to republish the article in whole or in part, with or without fee; 3) the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and 4) the right to republish the work in a collection of articles in any other mechanical or electronic format.

Most read articles by the same author(s)